[NEU] YoY Quarter Result on 31-Dec-2022 [#Q4]

Stock
[NEU] Neuren Pharmaceuticals Limited
Announcement Date
30-Dec-2022
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- 202.61%
YoY- 4,157.65%
Quarter Report
NEU's Result
NEU's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 168,999 14,553 3,197 717 495 13,990 631 153.78%
PBT 155,501 6,374 -3,027 -5,149 -3,426 7,169 6,840 68.27%
Tax 46,225 -864 -3,197 -717 -495 0 0 -
NP 109,276 7,238 170 -4,432 -2,931 7,169 6,840 58.66%
Tax Rate -29.73% 13.56% - - - 0.00% 0.00% -
Total Cost 59,723 7,315 3,027 5,149 3,426 6,821 -6,209 -
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin 64.66 49.74 5.32 -618.13 -592.12 51.24 1,083.99 -37.47%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS 0.86 0.06 0.00 -0.04 -0.03 0.07 0.07 51.87%
EPS Diluted 0.83 0.06 0.00 -0.04 -0.03 0.07 0.07 50.97%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.